Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection Due to Resistant Organism”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Study completedNCT00079989
What this trial is testing

Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms

Who this might be right for
Gram-Negative Bacterial Infections
Wyeth is now a wholly owned subsidiary of Pfizer 115
Early research (Phase 1)Ended earlyNCT02922816
What this trial is testing

FMT for MDRO Colonization After Infection in Renal Transplant Recipients

Who this might be right for
Infection Due to Resistant Organism
Emory University 11
Testing effectiveness (Phase 2)Study completedNCT03367910
What this trial is testing

Fecal Microbiota Transplantation (FMT) for MDRO UTI

Who this might be right for
Urinary Tract Infections
Washington University School of Medicine 1
Not applicableNo Longer AvailableNCT01659515
What this trial is testing

Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria

Who this might be right for
Infection Due to Resistant Organism
U.S. Army Medical Research and Development Command
Early research (Phase 1)WithdrawnNCT02816437
What this trial is testing

FMT for MDRO Colonization in Solid Organ Transplant

Who this might be right for
Infection Due to Resistant Organism
University of Miami
Not applicableStudy completedNCT01764490
What this trial is testing

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study

Who this might be right for
Clinically Significant Bacteremia
JESUS RODRIGUEZ BAÑO 1,344
Not applicableStudy completedNCT02852902
What this trial is testing

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.

Who this might be right for
Clinically Significant BacteremiaOrgan TransplantationInfection+6 more
Spanish Network for Research in Infectious Diseases 820
Not applicableUnknownNCT03578835
What this trial is testing

Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes

Who this might be right for
Bloodstream InfectionSeptic Shock
University Hospital Tuebingen 6,000